Top compounds associated with response to RP11-240B13.2


Feature Type Standardized
Nominal ANOVA
mRNA tigecycline CTRPv2 pan-cancer AAC 0.0073 0.9
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.0055 0.9
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.0052 0.9
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0052 0.9
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.0049 0.9
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.005 0.9
mRNA CIL55 CTRPv2 pan-cancer AAC 0.0086 0.9
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0039 0.9
mRNA BRD9647 CTRPv2 pan-cancer AAC -0.0051 0.9
mRNA SCH-79797 CTRPv2 pan-cancer AAC -0.0047 0.9
Download CSV